Bristol-Myers Squibb to acquire Mirati Therapeutics for $4.8B
Drew Angerer/Getty Images News Bristol-Myers Squibb (NYSE:BMY) agreed to purchase cancer drug maker Mirati Therapeutics (NASDAQ:MRTX) for about $4.8 billion. ...
Drew Angerer/Getty Images News Bristol-Myers Squibb (NYSE:BMY) agreed to purchase cancer drug maker Mirati Therapeutics (NASDAQ:MRTX) for about $4.8 billion. ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.